Home/Filings/4/0001437749-19-016066
4//SEC Filing

Duckers Eric 4

Accession 0001437749-19-016066

CIK 0000925741other

Filed

Aug 7, 8:00 PM ET

Accepted

Aug 8, 4:41 PM ET

Size

11.9 KB

Accession

0001437749-19-016066

Insider Transaction Report

Form 4
Period: 2019-07-05
BioCardia, Inc.BCDA;BCDAW
Duckers Eric
Chief Medical Officer
Transactions
  • Conversion

    Common Stock

    2019-08-06$3.00/sh+8,435$25,3058,435 total
  • Purchase

    Convertible promissory note

    2019-07-05$25000.00/sh
    Exercise: $8.00From: 2019-07-05Exp: 2020-01-05Common Stock (3,125 underlying)
  • Conversion

    Convertible promissory note

    2019-08-06
    Exercise: $3.00From: 2019-07-05Exp: 2020-01-05Common Stock (8,435 underlying)
  • Purchase

    Warrant (right to buy)

    2019-08-06+8,4358,435 total
    Exercise: $6.30From: 2019-08-06Exp: 2024-08-06Common Stock (8,435 underlying)
Footnotes (1)
  • [F1]These securities were issued upon automatic conversion of a Convertible Promissory Note (the "Note") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offered in the public offering at 50% of the price to the public for such securities in such offering. The Registrant closed a public offering of units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit.

Issuer

BioCardia, Inc.

CIK 0000925741

Entity typeother

Related Parties

1
  • filerCIK 0001686154

Filing Metadata

Form type
4
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 4:41 PM ET
Size
11.9 KB